Clinical Oncology NGS Market: Emerging as a Hub for Genomic Innovation, Demand by 2034
The North America Clinical Oncology Next Generation Sequencing (NGS) market is playing a pivotal role in advancing precision oncology by enabling faster, more accurate, and comprehensive genomic profiling for cancer diagnosis and treatment selection. The United States remains at the … Read more